A novel dermal matrix generated from burned skin as a promising substitute for deep‑degree burns therapy.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26846279)

Published in Mol Med Rep on February 04, 2016

Authors

Guanying Yu1, Lan Ye1, Wei Tan2, Xuguo Zhu1, Yaonan Li1, Duyin Jiang1

Author Affiliations

1: Department of Burns and Plastic Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.
2: Department of Gastrointestinal Surgery, Jinan Central Hospital, Jinan, Shandong 250013, P.R. China.

Articles cited by this

Cutaneous wound healing. N Engl J Med (1999) 19.12

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14

The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63

The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65

The extracellular matrix as a biologic scaffold material. Biomaterials (2007) 3.18

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J (2000) 2.44

Wound repair and regeneration. Eur Surg Res (2012) 2.35

The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res (2009) 2.34

The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol (2004) 2.01

Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation (2001) 1.90

Cells mediating allograft rejection. Transplantation (1991) 1.37

Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr Surg (2004) 1.34

Collagen denaturation can be quantified in burned human skin using polarization-sensitive optical coherence tomography. Burns (2004) 1.31

Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg (2008) 1.24

Origin of the metazoan immune system: identification of the molecules and their functions in sponges. Integr Comp Biol (2003) 1.22

The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg (2005) 1.21

Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg (1978) 1.15

Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma (1993) 1.14

Cytokine response to burn injury: relationship with protein metabolism. J Trauma (1994) 1.11

Engineering functionally graded tissue engineering scaffolds. J Mech Behav Biomed Mater (2007) 1.10

Tissue engineering of skin. Crit Rev Oral Biol Med (1998) 1.10

"Xenograft" dressing in the treatment of burns. Clin Dermatol (2005) 1.08

A porcine deep dermal partial thickness burn model with hypertrophic scarring. Burns (2006) 1.05

Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns (2009) 1.03

Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds (2005) 1.02

Treatment of severe burn with DermACELL(®), an acellular dermal matrix. Int J Burns Trauma (2012) 1.02

The effect of burn injury on suppressors of cytokine signalling. Shock (2000) 0.98

Plasma cytokines after thermal injury and their relationship to infection. Ann Surg (1993) 0.97

Comparison of five dermal substitutes in full-thickness skin wound healing in a porcine model. Burns (2012) 0.96

The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation (1993) 0.95

Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol (2007) 0.95

A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil (1997) 0.94

Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Repair Regen (2004) 0.94

Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Biochem J (2001) 0.93

Control of hypertrophic scar from inception by using xenogenic (porcine) acellular dermal matrix (ADM) to cover deep second degree burn. Burns (2006) 0.93

IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. J Immunol (2002) 0.92

Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways. J Periodontal Res (2006) 0.92

Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. J Burn Care Res (2012) 0.89

Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. Matrix Biol (2014) 0.88

Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg (1996) 0.88

Burn toxin in mouse skin. J Trauma (1973) 0.88

Mechanisms of immune failure in burn injury. Vaccine (1993) 0.87

The impact of burn injury and ethanol on the cytokine network of the mouse hypothalamus: reproductive implications. Cytokine (2005) 0.85

Experimental evidence for a significant impairment of host defense for gram-negative organisms by a specific cutaneous toxin produced by severe burn injuries. Surg Gynecol Obstet (1975) 0.84

Suppressor cell induction by povidone-iodine: in vitro demonstration of a consequence of clinical burn treatment with betadine. J Immunol (1981) 0.84

Dental implants from functionally graded materials. J Biomed Mater Res A (2013) 0.84

The study of inhibiting systematic inflammatory response syndrome by applying xenogenic (porcine) acellular dermal matrix on second-degree burns. Burns (2007) 0.83

Current methods of burn reconstruction. Plast Reconstr Surg (2013) 0.83

The optimal time for early burn wound excision to reduce pro-inflammatory cytokine production in a murine burn injury model. Burns (2010) 0.82

A preliminary investigation of the reinnervation and return of sensory function in burn patients treated with INTEGRA®. Burns (2011) 0.81

The effect of porcine ADM to improve the burn wound healing. Int J Clin Exp Pathol (2013) 0.81

Porcine skin: friend or foe? Burns (2004) 0.81

Thermal capsulorrhaphy treatment of shoulder instability: basic science. Clin Orthop Relat Res (2001) 0.81

Surgical management of the burn wound and use of skin substitutes: an expert panel white paper. J Burn Care Res (2013) 0.80

Early surgical excision and grafting of burns including tangential excision. Prog Pediatr Surg (1981) 0.79

Cryopreserved cadaveric allografts for treatment of unexcised partial thickness flame burns: clinical experience with 12 patients. Burns (1998) 0.79

Characterization and in vitro evaluation of electrospun chitosan/polycaprolactone blend fibrous mat for skin tissue engineering. J Mater Sci Mater Med (2015) 0.79

Biocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanofibers for skin tissue engineering. J Biomed Nanotechnol (2013) 0.78

Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor. Exp Cell Res (1993) 0.78

Short-term in vitro and in vivo biocompatibility of a biodegradable polyurethane foam based on 1,4-butanediisocyanate. J Mater Sci Mater Med (2005) 0.78

Comparison of endotoxins and cutaneous burn toxin as immunosuppressants. Burns (1990) 0.78

Circulating mediators in thermal injuries: isolation and characterization of a burn injury-induced immunosuppressive serum component. J Burn Care Rehabil (1987) 0.78

Xenogenic (porcine) acellular dermal matrix is useful for the wound healing of severely damaged extremities. Exp Ther Med (2014) 0.76

Design and Construction of Artificial Extracellular Matrix (aECM) Proteins from Escherichia coli for Skin Tissue Engineering. J Vis Exp (2015) 0.76

Toxin-specific ultrastructural alterations of the mouse liver after burn injuries and the possibility of a specific antitoxic therapy. Scand J Plast Reconstr Surg (1979) 0.76

[Experimental study on the recycling of denatured acellular dermal matrix after burn]. Zhonghua Shao Shang Za Zhi (2012) 0.76

Effects of peptide hormones on urea- and glycogen-synthesis of isolated hepatocytes and the influence of a toxic factor from burnt mouse and human skin. Horm Metab Res (1982) 0.76

Biomaterials. Introduction. Science (2012) 0.76

Serum lipid peroxide levels of patients suffering from thermal injury. Burns Incl Therm Inj (1984) 0.76

Plasma levels of cutaneous burn toxin and lipid peroxides in thermal injury. Burns (1990) 0.76

[Study on the management of postburn pathological scars]. Zhonghua Shao Shang Za Zhi (2004) 0.76

[Clinical observation of the effect of tangential excision within 24 postburn hours on the patients with deep partial thickness burn]. Zhonghua Shao Shang Za Zhi (2003) 0.76

[The manufacturing and clinical application of heterogenous acellular dermal matrix]. Zhonghua Shao Shang Za Zhi (2002) 0.76

Burn toxins isolated from mouse and human skin. Their characterization and immunotherapy effects. Monogr Allergy (1975) 0.75

[The clinical staging and tissue bacterial quantification in the diagnosis of burn wound sepsis]. Zhonghua Shao Shang Za Zhi (2003) 0.75